Si prevede che il mercato degli analizzatori per emostasi raggiungerà i 6.490,24 milioni di dollari entro il 2028 rispetto ai 3.440,66 milioni di dollari del 2021; si prevede che registrerà un CAGR del 9,5% dal 2021 al 2028.
Gli analizzatori di emostasi forniscono una misurazione rapida e semplice dei livelli di piastrine nel sangue. Un test di coagulazione potrebbe aiutare a rilevare e prevenire la formazione di coaguli di sangue che potrebbero causare un infarto. Un analizzatore della coagulazione può misurare la velocità del percorso della coagulazione e la quantità di trombolina e tromboplastina in meno di pochi minuti. È probabile che le malattie cardiovascolari (CVD) rimangano la causa più significativa di morbilità e mortalità in tutto il mondo. Le malattie cardiovascolari sono disturbi del cuore e dei vasi sanguigni e comprendono malattie cerebrovascolari, malattie coronariche, malattie cardiache reumatiche e altre condizioni. Alcuni problemi legati allo stile di vita che portano a malattie e difficoltà cardiovascolari sono l’uso del tabacco, una dieta non sana e l’inattività fisica. Aumentano il rischio di infarti e ictus. Altri fattori di rischio per le malattie cardiovascolari sono l’ipertensione, il diabete e l’aumento dei livelli di colesterolo. Secondo l'Organizzazione Mondiale della Sanità (OMS), le malattie cardiovascolari sono la prima causa di morte a livello globale.
Approfondimenti strategici
Regioni redditizie per il mercato degli analizzatori di emostasiApprofondimenti di mercato
L'aumento della popolazione geriatrica spingerà il mercato degli analizzatori di emostasi
Gli anziani sono soggetti a malattie cardiache a causa della debole immunità e di altri fattori problemi di salute. I fattori generali dell’invecchiamento portano all’irrigidimento del cuore e dei vasi sanguigni che provocano disturbi cardiaci. Con l’avanzare dell’età aumenta anche la pressione arteriosa sistolica, portando a malattie cardiovascolari (CVD). Pertanto, nelle persone di età pari o superiore a 75 anni, l’ipertensione è un fattore di rischio comune per le malattie cardiache. La malattia coronarica e l'insufficienza cardiaca sono le altre. Sebbene l'incidenza delle aritmie comprenda persone di tutte le fasce d'età, sta aumentando in modo significativo tra la popolazione geriatrica.
Secondo il sondaggio Global Aging 2019, la popolazione mondiale di 65 anni e oltre ammontava a 703 milioni nel 2019. Si prevede che la popolazione anziana raddoppierà fino a raggiungere 1,5 miliardi di persone entro il 2050. È probabile che la frequenza di una persona di età pari o superiore a 65 anni aumenterà da 1 su 11 abitanti nel 2019 a 1 su 6 abitanti entro il 2025. Questa fascia demografica è più suscettibile a CVD, come le aritmie. Allo stesso modo, secondo l’Organizzazione Mondiale della Sanità (OMS), si stima che la percentuale di persone di età pari o superiore a 60 anni raggiungerà il 22% entro il 2050 dal 12% del 2015. Secondo il rapporto “Older Americans 2016: Key Indicators of Well-Being” secondo il Federal Interagency Forum on Aging-Related Statistics, il 35,8% degli individui di età pari o superiore a 85 anni presentava un disturbo cognitivo lieve o estremo. Inoltre, secondo il rapporto World Population Aging 2017 delle Nazioni Unite, nel 2017, 962 milioni di persone avevano 60 anni o più in tutto il mondo e si prevede che il numero raggiungerà quasi 2,1 miliardi entro il 2050.
La popolazione anziana è più inclini a presentazioni atipiche, condizioni di comorbilità ed esiti sfavorevoli. La ragione principale delle malattie è legata ai cambiamenti strutturali e funzionali del sistema cardiovascolare associati all'invecchiamento. L'aumento della popolazione geriatrica globale sta portando a un aumento delle malattie cardiovascolari, che, a sua volta, sta stimolando la domanda di analizzatori dell'emostasi.
Approfondimenti basati sul tipo di prodotto
In base al tipo di prodotto, il mercato degli analizzatori dell'emostasi è ulteriormente segmentato in analizzatori di laboratorio e sistemi di test point-of-care. Nel 2021, il segmento degli analizzatori di laboratorio detiene la quota maggiore del mercato e si stima che il segmento dei sistemi di test point-of-care registrerà il CAGR più elevato nel periodo 2021-2028.
Quota di mercato degli analizzatori di emostasi, per Tipo di prodotto: 2021 e 2028
Approfondimenti basati su test
Sulla base dei test, il mercato è segmentato in tempo di tromboplastina parziale attivata, test del D-dimero, test del fibrinogeno, test del tempo di protrombina, e altri. Nel 2021, il segmento temporale della tromboplastina parziale attivata deteneva la quota maggiore del mercato. Si prevede che il segmento dei test del tempo di protrombina registrerà il CAGR più elevato del mercato nel periodo dal 2021 al 2028.
Approfondimenti basati sugli utenti finali
In base agli utenti finali, il mercato è segmentato in ospedali /cliniche, laboratori diagnostici indipendenti, strutture di assistenza domiciliare e altri. Nel 2021, il segmento ospedali/cliniche rappresentava la quota maggiore del mercato. Si prevede che il segmento dei laboratori diagnostici indipendenti registrerà il CAGR più elevato del mercato nel periodo dal 2021 al 2028.
Le aziende che operano nel mercato degli analizzatori di emostasi sottolineano l'adozione della strategia di innovazioni di prodotto per soddisfare le richieste in evoluzione dei clienti in tutto il mondo, che anche consente loro di mantenere il proprio marchio nel mercato globale.
Mercato degli analizzatori di emostasi: – Segmentazione
Il mercato degli analizzatori dell'emostasi è segmentato in base al tipo di prodotto, al test e all'utente finale. In base al tipo di prodotto, il mercato degli analizzatori dell’emostasi è segmentato in analizzatori di laboratorio e sistemi di test point-of-care. Sulla base del test, il mercato è ulteriormente segmentato in tempo di tromboplastina parziale attivata, test del D-dimero, test del fibrinogeno, test del tempo di protrombina e altri. In base all’utente finale, il mercato è segmentato in ospedali/cliniche, laboratori diagnostici indipendenti, strutture di assistenza domiciliare e altri. In termini geografici, il mercato degli analizzatori di emostasi è segmentato in Nord America (Stati Uniti, Canada e Messico), Europa (Francia, Germania, Italia, Regno Unito, Spagna e resto d’Europa), Asia Pacifico (Australia, Cina , India, Giappone, Corea del Sud e resto dell'APAC), Medio Oriente e altri paesi. Africa (Arabia Saudita, Sud Africa, Emirati Arabi Uniti e resto del MEA) e America meridionale e centrale (Brasile, Argentina e il resto di SCAM)
Profili aziendali
- Siemens AG
- Laboratorio di strumentazione
- Abbott
- Sysmex Corporation
- Nihon Kohden Corporation
- Thermo Fisher Scientific Inc.
- Roche Diagnostics
- Diagnostica Stago
- Helena Laboratories
- International Technidyne Corporation.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Hemostasis analyzers are medical devices that are used to measure the clotting time of hemostasis to detect clotting deficiencies and facilitate the treatment of patients with an excess bleeding condition by medical practitioners.
The factors driving and restraining the hemostasis analyzers market in the coming years include the high prevalence of cardiovascular diseases and the rise in the geriatric population. However, the high cost of a fully automated hemostasis analyzer is likely to hamper the market's growth.
The hemostasis analyzers market majorly consists of the players such as Siemens AG, Instrumentation Laboratory, Abbott, Sysmex Corporation, Nihon Kohden Corporation, Thermo Fisher Scientific Inc., Roche Diagnostics, Diagnostica Stago, Helena Laboratories, International Technidyne Corporation are amongst others.
The global hemostasis analyzers market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. In the North America region, the market for hemostasis analyzers market is primarily held by the US among the other countries. The growth of the hemostasis analyzers market in the United States is expected to grow owing to increasing organic developments by the market players in the market, rising awareness among consumers for treatment, and an increase in the prevalence of chronic illnesses like blood disorders and cardiovascular diseases.
The global hemostasis analyzers market based on product is segmented into product type [laboratory analyzer (automated systems, semi-automated systems, and manual systems) and point-of-care testing systems. In 2021, the laboratory analyzer segment held the largest share of the market by product and point-of-care testing systems is expected to witness the fastest CAGR during 2021 to 2028.
The Asia Pacific is expected to be the fastest-growing region and is likely to expand at a high growth rate due to the rising development in the pharmaceutical sector. Also, the rise in the incidence of cardiovascular diseases is likely to provide more significant growth opportunities to the market players in the coming years is likely to boost the growth of the market in the Asia Pacific region.
The List of Companies - Hemostasis Analyzers Market
- Siemens AG
- Instrumentation Laboratory
- Abbott
- Sysmex Corporation
- Nihon Kohden Corporation
- Thermo Fisher Scientific Inc.
- Roche Diagnostics
- Diagnostica Stago
- Helena Laboratories
- International Technidyne Corporation
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Dec 2021
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Dec 2021
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Dec 2021
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Dec 2021
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Dec 2021
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Dec 2021
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Dec 2021
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography
Dec 2021
Lung Cancer Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Noninvasive and Minimally Invasive), Indication (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), End User (Hospitals, Oncology Clinics, Research Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)